Science & Enterprise subscription

Follow us on Twitter

  • A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV… https://t.co/Gl4q8GAZBg
    about 3 hours ago
  • New post on Science and Enterprise: Sensor in Works Detecting Covid-19 Airborne Virus https://t.co/gQ7LuZ5Qv1 #Science #Business
    about 3 hours ago
  • A company designing microscale robotic devices to deliver therapies to the central nervous system began work in pub… https://t.co/SUbHXwULXG
    about 5 hours ago
  • New post on Science and Enterprise: Micro Robotic Neuro Therapy Company Underway https://t.co/Lfm9Nysgd3 #Science #Business
    about 5 hours ago
  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 1 day ago

Please share Science & Enterprise

Biotech Licenses Precision Cancer Biologic to Genentech

DNA illustration

A biotechnology company discovering synthetic proteins that target cancer-causing genetic mutations is licensing its lead product to biologics maker Genentech. . . . → Read More: Biotech Licenses Precision Cancer Biologic to Genentech

Trial Shows Stem Cell Therapy Slows M.S. Progression

Neuron

Results of a clinical trial show a treatment for multiple sclerosis from patients’ stem cells slows progression of the disease and improves walking ability. . . . → Read More: Trial Shows Stem Cell Therapy Slows M.S. Progression

Bayer Gains Lung Cancer Therapy in $670M Deal

Lung cancer illustration

Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics. . . . → Read More: Bayer Gains Lung Cancer Therapy in $670M Deal

Crispr Edits Out HIV-Like Genes from Monkey DNA

Kamel Khalili and Tricia Burdo

Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies. . . . → Read More: Crispr Edits Out HIV-Like Genes from Monkey DNA

Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Inspecting lung X-rays

Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Start-Up Gains Drug Nanoparticle Manufacturing Tech

Small bubbles

A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech

Oral Drug Delivery Company Acquired in $1.8B Deal

Investor screen

Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk. . . . → Read More: Oral Drug Delivery Company Acquired in $1.8B Deal

Covid-19 Drug Biotech Raises $300M in IPO

Wall Street sign

A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock. . . . → Read More: Covid-19 Drug Biotech Raises $300M in IPO

Novartis Gains Synthetic Protein Therapies for Covid-19

SARS-CoV-2 and cell

Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components. . . . → Read More: Novartis Gains Synthetic Protein Therapies for Covid-19

Precision Drug Trial Shows Solid Tumor Shrinkage

Cancer on clipboard

Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types. . . . → Read More: Precision Drug Trial Shows Solid Tumor Shrinkage